1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow saroglitazar: new trials by email Literature Review of saroglitazar trials Research Report on saroglitazar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities Saroglitazar - NAFLD, Obesity | Phase 4 | Unknown | Zydus Lifesciences Limited | 1500 | 2023-07-20 | 2024-02-07 |
Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Metabolic Syndrome (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1)
Zydus Lifesciences Limited (1)
India (1)